The Aortix™ device is an investigational device that is being evaluated in clinical trials in the United States and Australia.
Enrollment completed
The Aortix CRS Pilot Study (NCT04145635) has completed enrolling patients admitted to the hospital with a primary diagnosis of acute decompensated heart failure.
The Aortix Therapy for Perioperative Reduction of Kidney Injury Study (NCT04999163) is currently enrolling patients in Australia who are undergoing cardiac surgery and at high risk of developing AKI.
